Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 21,039 shares at $6.65 ($143K) on 2022-01-10, disclosed to the SEC on 2022-01-11.
Open-market sale of $143k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 4,595 | $34K | 23.5% |
| 2 | $6.65 | 8,222 | $55K | 38.3% |
| 3 | $6.65 | 8,222 | $55K | 38.3% |
| Total | $6.79 avg | 21,039 | $143K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |